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Background: The release of neuron-specific astroglial S-100 protein to the
cerebrospinal fluid is a marker of cerebral damage. The aim of this study was
to determine the pattern of release of S-100 protein to serum after pediatric
cardiac operations and extracorporeal circulation. Methods: Sequential blood
samples from 97 children (up to 16 years) were taken after induction of
anesthesia, immediately after the discontinuation of extracorporeal circula-
tion, and 5 and 15 hours after extracorporeal circulation. The children were
divided into five groups including three age groups, children with Mb Down
syndrome, and children undergoing circulatory arrest. Results: The serum
concentrations of S-100 protein before the cardiac operation were found to be
highest in neonates. Children with Down syndrome, regardless of age, had
basal levels comparable to those in neonates. There was an increase in S-100
protein concentration immediately after extracorporeal circulation and a
multivariate regression analysis showed this difference in S-100 protein
concentration to be significant with respect to age (p 5 0.002), perfusion time
(p < 0.001), and circulatory arrest (p < 0.001), but the difference was not
significant with respect to weight, Down syndrome, and core temperature (p >
0.8). In children younger than 1 month old and after circulatory arrest, levels
of S-100 protein remained high at 5 hours after extracorporeal circulation.
Conclusion: These findings emphasize the necessity of using age-matched
reference values and taking perfusion time into consideration when S-100
protein levels are evaluated with respect to cerebral postperfusion injuries in
pediatric patients undergoing cardiac operations. (J Thorac Cardiovasc Surg
1998;116:281-5)
A cerebral complication after a pediatric cardiacoperation can be difficult to diagnose and to quan-
tify, because clinical expressions are blunted by seda-
tion and muscular relaxation. Continuous electroen-
cephalography, transcranial Doppler ultrasonography,
computed tomography, and magnetic resonance imag-
ing are methods that have been used to detect cerebral
injuries, but these methods are expensive and time
consuming. A specific biochemical marker for early
detection of cerebral complications after pediatric
cardiac operations would be of great value.1, 2
S-100 protein is a type of protein synthesized in
astroglial cells in all parts of the central nervous
system.3 Structural damage to the brain causes a
selective leakage into the cerebrospinal fluid of
S-100 protein. The aim of this study was to investi-
gate the occurrence of S-100 protein in serum in
pediatric patients undergoing cardiac operations
with extracorporeal circulation (ECC).
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During a 5-month period, we prospectively studied the
appearance of S-100 protein in serum in 91 children of
ages 0 to 16 years who were undergoing cardiac opera-
tions. In addition to these children and to enlarge the
number of children in one group we did a follow-up study
during the following 7 months in which we prospectively
studied six children younger than 1 month old, and these
children were included in the study.
Serum was analyzed for S-100 protein after the induc-
tion of anesthesia, immediately after the discontinuation
of ECC, and 5 and 15 hours after ECC. Postoperative
neurologic status was assessed daily by clinical examina-
tion.
The children were divided into three age groups and
two separate groups: (A) age 0 to 1 month (n 5 22); (B)
age 1 to 12 months (n 5 20); (C) age 1 to 16 years (n 5
48); (D) all children with Down syndrome, ages 4 months
to 6 years (n 5 7); and (E) all children undergoing
circulatory arrest procedures, ages 0 to 77 days, median 6
days (n 5 7).
Premedication consisted of rectally given midazolam
(0.5 mg/kg). Anesthesia was induced intravenously with
atropine (0.02 mg/kg), fentanyl (5 mg/kg), and thiopental
(5 to 7 mg/kg). Intubation was performed with the use of
pancuronium (0.2 mg/kg) relaxation. Anesthesia was
maintained by a low dose (0.5% to 1%) of halothane or
isoflurane and additional doses of fentanyl (5 mg/kg) were
given.
Cardiopulmonary bypass was performed with nonpul-
satile perfusion during hypothermia (arterial blood from
the oxygenator at 20° C) and when deep hypothermia and
circulatory arrest were applied (arterial blood at 8° C,
nadir temperatures of 15° to 20° C rectally and 12° to
15° C in hypopharynx). A membrane oxygenator (Cobe
VPCML, Gambro, Lund, Sweden) and arterial line filters
(Dideco D733 or D736, Ta¨by, Sweden) were used. The
circuit was primed with Ringer-acetate, mannitol, and
Addex-THAM, and in children with a weight of less than
12 kg erythrocyte concentrate was added. The pump flow
and mean arterial blood pressure were adjusted to the
body surface and body temperature and if needed bolus
injections of norepinephrine (0.1 to 1 mg/kg) were given.
S-100 protein concentration was analyzed with use of a
commercially available monoclonal two-site immunora-
dioactive assay, which detects the ab and bb dimers
(Sangtec 100, Sangtec Medical, Bromma, Sweden) as
described by Westaby and associates.4 The blood samples
were centrifuged to separate the serum, frozen to –20° C,
and analyzed the next day. The lower sensitivity of the
assay was 0.2 mg/L.
Statistics. Computerized statistical analysis was per-
formed with the SPSS for Windows statistical program
(release 6.1). Data are presented as means plus or minus
the standard deviations. Differences in S-100 protein
levels between age groups were compared with unpaired
Student’s t tests and within groups A to E with Wilcoxon
signed rank tests. A multivariate linear regression with
differences in S-100 protein levels as dependent variables
and with Down syndrome, weight, perfusion time, core
temperature, circulatory arrest, and age (transformed by
logarithm) as independent variables was tested. Correla-
tion between differences in S-100 protein concentration
and perfusion time, hematocrit, nadir core temperature,
nadir perfusion pressure, and circulatory arrest time was
calculated by linear regression analysis.
Results
S-100 protein in serum was detected in all neo-
nates and some of the older children up to age 8
years immediately after induction of anesthesia but
before the operation. S-100 protein levels were
found to be highest in neonates, lower at ages
between 1 month and 1 year, and lowest at ages
older than 1 year (Fig. 1). Children with Down
syndrome, regardless of age, had levels comparable
to those in neonates (Fig. 2). The serum concentra-
tion of S-100 protein increased after ECC, but did
not reach statistical significance in group D (Fig. 2).
The multivariate regression showed that weight,
Down syndrome, and core temperature were all
nonsignificant (p . 0.80) related to the increase in
S-100 protein levels immediately after ECC,
whereas age (p 5 0.002), perfusion time (p , 0.001),
and circulatory arrest (p , 0.001) were significant.
With these three significant variables we were able
Fig. 1. Levels of S-100 protein before the operation in
three age groups. Median is used as midpoint. Upper box
value is the 75th percentile and lower box value is the 25th
percentile. The whiskers represent the nonoutlier range.
Outlier data points are represented by open circles. ***p ,
0.001 between group 0 to 31 days (n 5 22) and both group
1 to 12 months (n 5 20) and group 1 to 16 years (n 5 48).
###p , 0.001 between group 1 to 12 months and group 1
to 16 years.
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to explain 52% of the variation in S-100 protein level
(R2 5 0.52).
The linear regression analysis showed a correla-
tion between the difference in S-100 protein level
and perfusion time (r 5 0.58, p , 0.001) (Fig. 3) and
nadir core temperature during ECC (r 5 0.38,
p , 0.001). Circulatory arrest was shown in the
multivariate regression to be a strongly significant
variable related to the difference in S-100 protein
levels. Although the number of observations was
small (n 5 7) a linear regression performed with the
expectation that the S-100 protein level would in-
crease after the arrest showed a slight significance
(r 5 0.70, p 5 0.042). There was no correlation
between the increase in S-100 protein level and
hematocrit or nadir perfusion pressure during ECC.
In groups A and E the highest levels of S-100
protein appeared immediately after the discontinu-
ation of ECC and 5 hours after ECC. In groups B
and C the highest levels of S-100 protein appeared
immediately after ECC followed by a decrease 5
hours after ECC (Fig. 2). Children with Mb Down
syndrome, all of whom were older than 1 month,
showed levels after ECC comparable to levels in
neonates, but the change in the concentration of
S-100 protein after ECC was not significant versus
the concentration measured before ECC. The high-
est concentrations of S-100 protein appeared in
group E. The single highest value, 15 mg/L, obtained
5 hours after ECC, was noticed in a 3-day-old child
in whom epileptic seizures developed 24 hours after
ECC with hypothermic circulatory arrest. No clini-
cal neurologic deficit was noticed when sedation was
discontinued and the child was awake and extubated
2 days later.
Discussion
This study shows that measurable blood levels of
astroglial S-100 protein are present in neonates and
in some younger children before ECC. In children
older than age 8 years there were no detectable
levels of S-100 protein. The mean concentration of
S-100 protein was highest in neonates and decreased
with age. This is in contrast to findings in cerebro-
spinal fluid in which S-100 protein levels increased
with age from 0.7 to 66 years.5 The concentration of
S-100 protein in blood has always been below the
limit of detection in adult patients before sternoto-
my.4, 6, 7 This finding of detectable S-100 levels
before ECC in children shows that elevated concen-
trations of S-100 protein can appear in serum with-
out obvious cerebral injury. A less selective perme-
ability of the blood-brain barrier combined with a
higher protein turnover in the neuron cells because
of a fast maturation of the central nervous system in
children may contribute to this. A low renal excre-
tion may also contribute to an increased concentra-
tion of S-100 protein in serum in the youngest
children. However, these findings emphasize that a
moderately increased concentration of S-100 pro-
tein in adult patients must be interpreted carefully
and may be caused by a reversible injury to the
endothelial cells of the blood-brain barrier or a
decrease in renal function during and after ECC.
The finding of an increased concentration of
S-100 protein in children with Down syndrome may
be explained by the duplication of chromosome 21,
perhaps in conjunction with a more permeable
blood-brain barrier. The S-100 protein gene is lo-
cated on chromosome 1q21.3
Fig. 2. Concentrations of S-100 protein in serum in
groups A through E before ECC, immediately after ECC,
and 5 hours and 15 hours after ECC (means and standard
deviations are shown).
Fig. 3. Correlation between the increase in S-100 protein
level immediately after ECC and perfusion time (n 5 80,
r 5 0.58, p , 0.001): 95% confidence limits are indicated.
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Our results show a significant correlation between
the increase in S-100 protein levels and duration of
ECC, which is in agreement with the findings of
Westaby and associates4 in adult patients. We also
found a correlation between the increase in S-100
protein level and the nadir core temperature during
ECC. Kumar and associates7 suspected that the
nadir core temperature in their patients might have
influenced the S-100 protein release. They found
higher S-100 protein levels in patients who were
operated on at lower temperatures. However, chil-
dren with a long perfusion time tend to have a lower
nadir core temperature during ECC and our multi-
variate regression indicated that nadir core temper-
ature was merely covariate with perfusion time and
was not a significant cause of the increase in S-100
protein concentrations immediately after ECC. The
relation between the increase in S-100 protein level
immediately after ECC and circulatory arrest is
interesting and more observations might help to
better define the correlation between difference in
S-100 protein level and circulatory arrest time.
It has been suggested that the concentration of
S-100 protein in cerebrospinal fluid may be used to
estimate the size of an ischemic brain injury,8 and it
has also been suggested that the release of S-100
protein during ECC may be associated with a flow-
related microembolization to the brain.4, 9 We did
not notice any clinical signs of postoperative neuro-
logic injury, except in one child with transient epi-
leptic seizures. More extensive neurophysiologic
tests were not applied.
Our highest levels of S-100 protein appeared
immediately after ECC followed by a decline, except
after circulatory arrest and in neonates, in which
cases the decline was not detected until 15 hours
after ECC. Other researchers have detected the
highest levels of S-100 protein after ECC followed
by a continuous decline.4, 6 In a situation with exten-
sive microembolization to the brain it seems more
likely that a release of S-100 protein from unper-
fused brain areas would be postponed until the
cellular breakdown appears. A more plausible ex-
planation for the initial increase in S-100 protein
level is therefore an increased permeability of the
blood-brain barrier. The systemic inflammatory re-
sponse syndrome and endothelial cell activation and
injury are well known after cardiac operations.10, 11
The endothelium-leukocyte interaction with release
of inflammatory mediators leads to damage of en-
dothelial integrity, sticking of leukocytes in the
microcapillary bed, and microcirculatory dysfunc-
tion. The increase in endothelial permeability could
explain the augmented release of S-100 protein to
the blood. This is in agreement with the finding of
cerebral edema in normal patients after cardiopul-
monary bypass investigated by magnetic resonance
imaging.12 The use of a bioactive heparin–coated
surface in the cardiopulmonary bypass circuit, which
attenuates the cellular and humoral response to
ECC, also decreases the release of S-100 protein
after ECC in adults and improves cerebral protec-
tion.13 The endothelial activation seems to be more
extensive in less mature children and in children
after circulatory arrest, judged by the peak levels of
S-100 protein in our study. The use of a bioactive
heparin–coated surface during ECC in these chil-
dren might therefore be beneficial. Because the
biologic half-life of S-100 protein has been esti-
mated to be about 2 hours, the delay in elimination
in neonates and after circulatory arrest could indi-
cate a continuous release of S-100 protein from the
brain. However, a decrease in glomerular filtration
rate can also contribute to this.
In conclusion, we have found increased postper-
fusion levels of S-100 protein in children, with the
highest values seen after circulatory arrest proce-
dures. For further investigation of S-100 protein as a
marker for cerebral injury, age and perfusion time
have to be taken into consideration.
We thank Bo Gullberg, senior lecturer in medical
statistics, Department of Statistics, University of Lund,
Sweden, for his assistance with the statistical procedures.
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Commentary
Overt cerebral injury occurs in a small percentage of
patients after cardiac surgery and presents little problem
in diagnosis. One the other hand, there is no easy method
of detecting the subtle cerebral injury, evidenced by
dysfunction in higher cognitive domains, which occurs in
two thirds of patients soon after surgery and which persists
in up to one third. In addition to the practical limitations
of electroencephalography, computed tomography, mag-
netic resonance imaging, and transcranial Doppler ultra-
sonography, interpretation of abnormalities and their
functional significance can be difficult. Neuropsychologic
testing reproducibly detects cognitive dysfunction but is
laborious and time consuming for both patients and
examiners (limitations that are exaggerated or insur-
mountable in the pediatric population). The availability of
a serum marker of cerebral injury would therefore be of
considerable value.
S-100 protein represents a group of astroglial proteins
widely distributed in the central nervous system. After
head injury or cerebrovascular accident, S-100 protein
leaks from structurally damaged cells into cerebrospinal
fluid and then blood, where its serum levels give some
indication of the magnitude of structural injury. Over the
past few years, a number of investigators have docu-
mented minor and transient elevations in serum S-100
protein levels after cardiac surgery and assumed, in the
absence of overt cerebral damage, that this represents
subtle cerebral injury.
The current study by Lindberg and colleagues addresses
the important question of cerebral injury after pediatric
surgery1 and describes serial alterations in S-100 protein
levels. While confirming a pattern of postoperative release
broadly similar to that in adults, it provides further
important observations regarding the kinetics of S-100
protein in children. Unlike the situation in adults, S-100
protein is detectable in the preoperative period in younger
children and those with Down’s syndrome. In an elegant
analysis of their data, Lindberg and colleagues report that
postoperative elevations in S-100 protein level correlate
with younger age, increasing duration of perfusion, and
the use of circulatory arrest. The title of the manuscript
teasingly describes S-100 protein as a possible new marker
for postperfusion cerebral injury, and this is, indeed, a
tantalizing prospect. But is it likely?
Although large and prolonged increases in S-100 pro-
tein after cardiac surgery (in the absence of renal failure)
have been correlated with structural brain injury, the
functional significance of the more commonly observed
pattern of early, modest, and temporary elevations in
S-100 protein soon after cardiopulmonary bypass is un-
certain. This may simply represent a cellular “washout”
phenomenon accompanied by a temporary increase in the
permeability of the blood-brain barrier as opposed to true
neuronal injury. If so, the value of S-100 as a marker of
subtle cerebral injury is reduced.
Interpretation of the significance of modest postopera-
tive elevations in S-100 protein is compounded in the
pediatric population because of its detectability in the
preoperative period, its variability with age, conflicting
evidence over the effects of hypothermia on its release,
and the need for total circulatory arrest. Furthermore, as
my colleagues and I2 have previously reported, intracar-
diac surgery itself results in larger postoperative eleva-
tions in S-100 protein.
Lindberg and colleagues are to be congratulated on an
excellent observational study. However, until there is
substantial evidence correlating modest postoperative el-
evations in S-100 protein levels with structural and/or
functional neuronal injury, the clinical significance of such
findings must be interpreted cautiously.
David P. Taggart, MD
Oxford, United Kingdom
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